Zhejiang Orient Gene Biotech Co., Ltd (SHA:688298)

Market Cap	3.78B -17.1%
Revenue (ttm)	1.01B +20.9%
Net Income	-551.99M
EPS	-2.91
Shares Out	193.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	861,509
Open	19.70
Previous Close	19.56
Day's Range	19.05 - 19.70
52-Week Range	19.10 - 30.65
Beta	0.82
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:688298

Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products worldwide. Its products include POCT instant diagnostic reagents, used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company offers its products for various categories, including COVID-19 diagnosis solutions; immunological diagnosis; quantum-beads flowcytometry; instrument; dry biochemical strips; raw materials; FISH probes; animal health; biochemistry; molecular diagn...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2005
• Employees: 2,434
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688298

Financial Performance

In 2025, SHA:688298's revenue was 947.38 million, an increase of 14.43% compared to the previous year's 827.92 million. Losses were -573.60 million, 8.43% more than in 2024.